BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9118164)

  • 21. A review of amlodipine in myocardial ischaemia.
    Taylor SH
    Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.
    Glasser SP; Bittar N; Labreche DG; Singh B; Katz R; Schulman P
    Am J Cardiol; 1994 Jun; 73(16):1165-8. PubMed ID: 7911271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic agents in the management of hypertension--nisoldipine coat-core.
    White WB
    J Clin Hypertens (Greenwich); 2007 Apr; 9(4):259-66. PubMed ID: 17396068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
    Hamilton SF; Houle LM; Thadani U
    Heart Dis; 1999; 1(5):279-88. PubMed ID: 11720635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of calcium antagonists on exercise tests.
    Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of amlodipine in the management of ischaemic heart disease.
    McGibney D
    Postgrad Med J; 1991; 67 Suppl 3():S24-8. PubMed ID: 1836871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
    Kobrin I; Bieska G; Charlon V; Lindberg E; Pordy R
    Cardiology; 1998; 89 Suppl 1():23-32. PubMed ID: 9570426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.
    Dens J; Desmet W; Piessens J
    Am Heart J; 2003 Mar; 145(3):404-8. PubMed ID: 12660661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open comparative study to assess the efficacy and safety of two calcium antagonists: amlodipine and diltiazem in the treatment of symptomatic myocardial ischemia.
    Canale C; Terrachini V; Masperone MA; Caponnetto S
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S57-60. PubMed ID: 16296712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful?
    Opie LH
    Am J Cardiol; 1997 May; 79(10A):29-32; discussion 47-8. PubMed ID: 9186064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.
    Glasser SP
    Am J Cardiol; 1995 Apr; 75(13):68E-70E. PubMed ID: 7726128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of amlodipine in stable effort angina. Comparison with diltiazem in terms of efficacy, tolerability and maintenance of the anti-ischemic action 24 hours after the last dose].
    Marchand X; Tibi T; Bernaud C; Morand P
    Ann Cardiol Angeiol (Paris); 1996 Feb; 45(2):74-82. PubMed ID: 8734139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Heart; 2003 Aug; 89(8):887-92. PubMed ID: 12860866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study to investigate the comparative efficacy and tolerability of nisoldipine coat-core and atenolol in the treatment of mild to moderate hypertension.
    Murray TS
    Br J Clin Pract; 1996; 50(7):368-72. PubMed ID: 9015908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nisoldipine in comparison with long-term nitrates].
    Eber B; Schumacher M; Zweiker R; Pokan R; Klein W
    Acta Med Austriaca; 1992; 19(5):137-9. PubMed ID: 1298142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silent myocardial ischemia: improvement with nisoldipine therapy.
    Glasser SP; Arce-Weston B; Clark PI
    South Med J; 1989 Jan; 82(1):32-4, 46. PubMed ID: 2643167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
    Grönefeld G; Bernhardt J; Schneider W
    Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.